Microbiological Assay Scientist, Mining

About the company
Fieldstone Bio is an early-stage synthetic biology company focused on environmental monitoring. Our technology, which originated at MIT, combines microbiology, synthetic biology, artificial intelligence, and advanced imagery to solve key challenges in mining, pollution surveillance, and national security.

Position summary
Fieldstone Bio is looking for a highly motivated Scientist to join our Reno, Nevada, Assay Team, where they will work to routinely run established assays for the identification of different metals in mining samples. The successful candidate will independently contribute to sample inventory management and spearhead the execution of established SOP workflows. This is a hands-on, lab-based role that will play a critical role in processing samples and delivering data to customers. This role is an opportunity to independently lead the execution of mining-sample workflow processing. This position will lead the development of Fieldstone’s presence in Reno, Nevada by supporting facility expansions and assay method optimization. The person in this role will report to the Head of Microbiology.

Key Responsibilities:

  • Receipt and organization of mining samples
  • Registration of materials for assay execution
  • Execute cell-based assays to screen for the presence of different metals in mining samples
  • Actively provide feedback on processes and offer solutions for methodology improvements
  • Preparation of assay working materials needed for each week
  • Work collaboratively with the AI Data Team to register and collect data for robust documentation practices
  • Ensure timely delivery of goals for set milestones
  • Document processes, results, and entity registration in an Electronic Lab Notebook (ELN) system

Qualifications:

  • PhD (or equivalent) in Microbiology, Bioengineering, Molecular Biology, or a related field
  • 1+ years’ of experience with assay execution (prior industry experience is strongly preferred)
  • Ability to work independently and manage multiple tasks simultaneously
  • Strong analytical and problem-solving skills
  • Excellent verbal and written communication
  • Diligent record keeper
  • Thrives in a fast-paced lab environment
  • Thrives working independently
  • Some travel to the Woburn, MA office is expected

Fieldstone Bio is committed to building a diverse and inclusive environment. All applicants will be considered without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status or disability.

EBRC Global Forum 4.0 (2027)

This is an invitation-only event.

 

MEETING OVERVIEW

Following the success of the prior Global Forum events in 2019, 2023, and 2025, EBRC will host the fourth Global Forum on Engineering Biology from February 24-26, 2027 at the Cumberland Lodge in Windsor, United Kingdom. This summit will focus on strengthening international collaboration in engineering biology while addressing emerging scientific, economic, and policy opportunities shaping the global bioeconomy.

During the two day meeting global participants from across government, academia, industry, and nonprofit organizations will convene to exchange perspectives on the future direction of engineering biology and identify areas where international cooperation can accelerate scientific progress, innovation, and responsible stewardship. The Forum is intentionally designed to create an environment that supports candid discussion, relationship building, and the exploration of new collaborative opportunities.

Key agenda topics will include:

  • Updates on national engineering biology strategies, investments, and policy initiatives;
  • Emerging trends in engineering biology research, innovation, and the global bioeconomy;
  • International approaches to governance, standards, and responsible innovation;
  • Opportunities to strengthen cross-border collaboration on research, workforce development, and technology translation.

 

VENUE

The Forum will take place at Cumberland Lodge in Windsor, United Kingdom. Situated within Windsor Great Park, Cumberland Lodge provides a historic residential conference venue designed to foster thoughtful discussion and collaboration among international leaders. All invited participants will stay on-site at Cumberland Lodge, allowing for continued engagement throughout the meeting and informal networking outside of scheduled sessions.

 

TRAVEL INFORMATION

Participants are responsible for arranging and covering the cost of their travel to and from Windsor, United Kingdom, as well as covering the costs of accommodations. EBRC will coordinate accommodations for all invited guests on-site at Cumberland Lodge for the duration of the Forum. Additional travel guidance, including recommended airports, ground transportation options, and arrival information, will be shared with confirmed attendees in advance of the meeting. Limited travel assistance may be available on a case-by-case basis for participants requiring financial support.

 

EBRC Global Forum 3.0 (2025)

The third EBRC Global Forum for Engineering Biology (EBRC Global Forum 3.0) took place on March 27th and 28th, 2025 at the J. Craig Venter Institute in La Jolla, California. This international summit brought together global leaders from across academia, industry, government, and nonprofit organizations, representing 23 countries, to discuss national strategies around engineering biology, emerging trends in the global bioeconomy, and opportunities for strengthening international collaboration.

     

Senior Biopharmaceutical Scientist

Why choose between doing meaningful work and having a fulfilling life? At MITRE, you can have both. That’s because MITRE people are committed to tackling our nation’s toughest challenges—and we’re committed to the long-term well-being of our employees. MITRE is different from most technology companies. We are a not-for-profit corporation chartered to work for the public interest, with no commercial conflicts to influence what we do. The R&D centers we operate for the government create lasting impact in fields as diverse as cybersecurity, healthcare, aviation, defense, and enterprise transformation. We’re making a difference every day—working for a safer, healthier, and more secure nation and world. Our workplace reflects our values. We offer competitive benefits, exceptional professional development opportunities for career growth, and a culture of innovation that embraces adaptability, collaboration, technical excellence, and people in partnership. If this sounds like the choice you want to make, then choose MITRE – and make a difference with us.

 

Department Summary:

MITREs Biotechnology and Life Sciences Department is a mission-focused scientific department dedicated to advancing pharmaceutical solutions that support U.S. defense and public health preparedness objectives. The department provides technical expertise accelerate the delivery of safe, effective Medical Countermeasures and ensure resilient pharmaceutical supply chains. Working across multidisciplinary teams, we support rapid development, technical problem-solving, and transition of drug products to meet operational, emergency response, and national security needs.

 

Roles & Responsibilities:

We are seeking an experienced Senior Pharmaceutical Scientist to lead the development of small molecule drug products supporting advanced research, development, manufacturing, and lifecycle management activities. This role will provide technical and strategic leadership across formulation development, process development, analytical characterization, manufacturing support, and supply chain resilience for orally delivered, injectable, topical, or other small molecule prophylactic and therapeutic products. The ideal candidate will bring expertise in small molecule pharmaceutical development and experience supporting Medical Countermeasures programs aligned with the mission needs of the U.S. Government, including candidate assessment, preclinical development, clinical-stage development (including under the animal rule), manufacturing, and transition to sustainment of products intended to address operational, emergency preparedness, and national security requirements.

  • Develop and evaluate technical and programmatic strategies for developing small molecule pharmaceutical products from preformulation through clinical and commercial readiness
  • Provide subject matter expertise related to formulation development, excipient compatibility, process scale-up and optimization, stability, dissolution, bioavailability, manufacturability, quality, and analytical method development for small molecule drug candidates
  • Support development of pharmaceutical products intended to meet Medical Countermeasures needs of the U.S. Department of War, including products relevant to force health protection, emergency response, and operational readiness
  • Investigate supply chain dependencies, bottlenecks, and chokepoints to inform U.S. strategies and programs to establish and sustain resilient pharmaceutical supply chains.
  • Provide technical leadership for drug product development activities involving tablets, capsules, suspensions, solutions, lyophilized products, injectables, or other small molecule dosage forms including combination products
  • Collaborate with cross-functional teams in R&D, manufacturing, quality, regulatory, clinical, and program management to advance small molecule development programs
  • Identify, assess, and develop mitigation strategies for technical, business, and programmatic risks to medical countermeasure development
  • Analyze complex data to support formulation selection, process robustness, product quality, and shelf-life determination
  • Author and review technical reports, development plans, study protocols, specifications, validation documents, deviation investigations, and regulatory submission content
  • Support scale-up, process transfer, and manufacturing readiness activities for pilot, clinical, and commercial production
  • Ensure work is conducted in compliance with applicable regulatory and quality standards, including cGMP, GLP, FDA regulations and guidance, and ICH guidelines
  • Serve as a trusted advisor to U.S. Government Sponsors.
  • Monitor scientific, regulatory, and industry trends relevant to small molecule therapeutics, pharmaceutical technologies, and defense-focused Medical Countermeasures programs

 

Basic Qualifications:

  • MS + 5 years of experience or Ph.D. +3 years of experience in Pharmaceutical Sciences, Chemistry, Medicinal Chemistry, Chemical Engineering, Pharmaceutics, or related scientific field
  • 3-5 years of experience in small molecule pharmaceutical development, drug product development, or related CMC functions
  • Strong expertise in formulation development, preformulation, analytical characterization, and process development for small molecule products
  • Experience with one or more dosage forms such as oral solids, sterile injectables, liquids, semi-solids, or modified-release systems
  • Demonstrated experience leading complex development programs and working across multidisciplinary teams
  • Strong understanding of cGMP, FDA regulatory expectations, ICH guidelines, and pharmaceutical quality systems
  • Excellent technical writing, data interpretation, problem-solving, and communication skills
  • Eligibility for a collateral Secret security clearance
  • Per the U.S. Government’s eligibility requirements, you must be a U.S Citizen to be considered for a security clearance.
  • This position requires a minimum of 50% hybrid on-site

 

Preferred Qualifications:

  • Experience supporting chemical, biological, radiological, or nuclear defense, epidemic response, or emergency preparedness medical countermeasure development programs
  • Experience with government-sponsored development environments, including collaboration with defense, public health, or federal R&D stakeholders
  • Experience supporting IND, NDA, or other regulatory submissions
  • Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society (RAPS)
  • Knowledge of technology transfer, process validation, and manufacturing support in a regulated environment
  • Experience with rapid development timelines, product shelf-life extension strategies, or deployment-oriented pharmaceutical requirements
  • Ability to work effectively in a fast-paced, matrixed, mission-driven environment

 

This requisition requires the candidate to have a minimum of the following clearance(s):

None

This requisition requires the hired candidate to have or obtain, within one year from the date of hire, the following clearance(s):

Secret

 

Salary compensation range and midpoint:

$119,500 – $149,500 – $179,500 Annual

 

Work Location Type:

Hybrid

It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.

 

Commitment to Non-Discrimination

All qualified applicants will receive consideration for employment without regard to disability, status as a protected veteran or any other status protected by applicable federal, state, local or international law.

MITRE intends to maintain a website that is fully accessible to all individuals. If you are unable to search or apply for jobs and would like to request a reasonable accommodation for any part of MITRE’s employment process, please email recruitinghelp@mitre.org for general support and collegerecruiting@mitre.org for intern positions. This service is for individuals requiring reasonable accommodation requests. Please note that vendor solicitations will not receive a reply.

Senior Scientist

Why choose between doing meaningful work and having a fulfilling life? At MITRE, you can have both. That’s because MITRE people are committed to tackling our nation’s toughest challenges—and we’re committed to the long-term well-being of our employees. MITRE is different from most technology companies. We are a not-for-profit corporation chartered to work for the public interest, with no commercial conflicts to influence what we do. The R&D centers we operate for the government create lasting impact in fields as diverse as cybersecurity, healthcare, aviation, defense, and enterprise transformation. We’re making a difference every day—working for a safer, healthier, and more secure nation and world. Our workplace reflects our values. We offer competitive benefits, exceptional professional development opportunities for career growth, and a culture of innovation that embraces adaptability, collaboration, technical excellence, and people in partnership. If this sounds like the choice you want to make, then choose MITRE – and make a difference with us.

Department Summary:

MITRE’s Biotechnology and Life Sciences Department is a mission-focused scientific department that brings multidisciplinary life science, engineering, analytic, and national security expertise to help government sponsors address complex biological threats and strengthen U.S. preparedness. The department supports mission needs in biodefense, biosecurity, CBRN/WMD defense, medical countermeasures, biosurveillance, health security, and the responsible application and advancement of emerging biotechnology.

 

Roles & Responsibilities:

We are seeking an experienced Senior Biodefense and Biosecurity Scientist with an active TS/SCI clearance to provide technical and strategic leadership across sensitive national security missions. The selected candidate will work with multidisciplinary teams and government sponsors to evaluate biological risks, strengthen preparedness, and develop actionable solutions. The ideal candidate will apply technical knowledge, systems-level thinking, and multidisciplinary approaches to address complex national biodefense challenges. Additional roles and responsibilities include:

  • Serve as a lead subject matter expert and trusted advisor on biodefense, biosecurity, biorisk management, biosurveillance, and biological threat preparedness for government sponsors.
  • Lead technical assessments of biological threats, emerging biotechnology, dual-use risks, system vulnerabilities, and preparedness gaps.
  • Develop actionable technical, operational, and policy recommendations that help sponsors prevent, detect, and respond to biological incidents.
  • Design and facilitate analyses, workshops, tabletop exercises, decision-support products, and strategic reviews that support sponsor planning and decision-making for complex biodefense and biosecurity challenges.
  • Engage across government, industry, academia, and MITRE to identify emerging risks, mature technical approaches, and transition solutions to mission use.
  • Author and brief technical reports, white papers, strategic assessments, and senior-leader briefings in classified and unclassified settings.
  • Mentor technical staff, contribute to work-shaping, and help grow MITRE’s biodefense work program.

 

Basic Qualifications:

  • Bachelor’s degree in biological sciences, microbiology, molecular biology, bioengineering, public health, biodefense, biosecurity, or a related field with a minimum of 5 years of related experience, or an equivalent combination of related education and work experience.
  • Demonstrated experience in biodefense, biosecurity, biorisk management, biosurveillance, health security, CBRN/WMD defense, biological threat reduction, or related national security mission areas.
  • Experience assessing biological threats, emerging biotechnology capabilities, vulnerabilities, or preparedness gaps and translating findings into sponsor-ready recommendations.
  • Experience leading multidisciplinary technical efforts and engaging senior government, defense, public health, academic, industry, or interagency stakeholders.
  • Excellent written and verbal communication skills, including experience producing briefings, technical reports, policy recommendations, and strategic assessments for senior decision-makers.
  • Active TS/SCI clearance at time of hire; ability to maintain TS/SCI access.
  • Per the U.S. Government’s eligibility requirements, you must be a U.S Citizen to be considered for a security clearance.
  • This position requires a minimum of 4 days a week on-site.

 

Preferred Qualifications:

  • Master’s degree, PhD, MD, or equivalent advanced degree in a relevant scientific or public health discipline.
  • 7+ years of experience supporting biodefense, biosecurity, biological threat assessment, CBRN/WMD defense, or related national security programs.
  • Extensive knowledge of established and emerging techniques for characterizing biological organisms including both computational and laboratory methods and spanning areas such as genomics, proteomics, metabolomics, and related analytical approaches.
  • Strong familiarity with modern biotechnology techniques across fields including synthetic biology, biosurveillance, bioinformatics, and bio-AI modeling and design tools.
  • Experience supporting federal national security, defense, intelligence, homeland security, and/or interagency biodefense sponsors in classified environments.
  • Experience conducting intelligence-informed biological threat assessments or supporting sensitive sponsor engagements involving biological threats, emerging biotechnology, or biorisk management.
  • Experience designing tabletop exercises, operational analyses, strategies, concepts of operation, roadmaps, and/or investment plans for biological preparedness and response.
  • Demonstrated ability to develop new work, lead task teams, mentor staff, and collaborate across scientific, technical, operational, and policy disciplines.
  • Familiarity with the application of AI techniques to biotechnology, assessing the risks AI/Bio poses, or potential applications of AI in the national security space.

 

This requisition requires the candidate to have a minimum of the following clearance(s):

Top Secret/SCI

This requisition requires the hired candidate to have or obtain, within one year from the date of hire, the following clearance(s):

Top Secret/SCI

 

Salary compensation range and midpoint:

$119,500 – $149,500 – $179,500 Annual

 

Work Location Type:

Onsite

 

Commitment to Non-Discrimination

All qualified applicants will receive consideration for employment without regard to disability, status as a protected veteran or any other status protected by applicable federal, state, local or international law.

MITRE intends to maintain a website that is fully accessible to all individuals. If you are unable to search or apply for jobs and would like to request a reasonable accommodation for any part of MITRE’s employment process, please email recruitinghelp@mitre.org for general support and collegerecruiting@mitre.org for intern positions. This service is for individuals requiring reasonable accommodation requests. Please note that vendor solicitations will not receive a reply.

Rodney Eric Williams

Rodney Eric Williams is a Science Policy Postdoctoral Fellow at the Engineering Biology Research Consortium (EBRC). Prior to EBRC he briefly served as a Postdoctoral Research Fellow in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He completed his PhD in Neuroscience at the Johns Hopkins University School of Medicine with Dr. Diane E. Griffin. His research focused on investigating the cellular and molecular mechanisms that drive neurological dysfunction during mosquito-borne viral infections to identify potential therapeutic targets.

Outside of the lab at Hopkins, Rodney served as president of the Johns Hopkins Medicine Graduate Student Association, as a Johns Hopkins Science Policy Fellow, and as a Graduate Policy Advisor to the Office of the Provost. He also served as a Howard Garrison Advocacy Fellow with the Federation of American Societies for Experimental Biology (FASEB).

When he is not working, Rodney loves to explore the outdoors, go for walks around the water, and attend the symphony.

EBRC 2026 Annual Meeting

Agenda

Program Book

 


Our 2026 Annual Meeting will be held June 2-3, 2026 at North Carolina State University in Raleigh, NC!

The EBRC Annual Meeting provides an opportunity for the engineering biology community to come together to engage on matters important to advancing engineering biology. In addition to inspiring research talks and poster presentations, EBRC’s meeting holds time to consider the larger engineering biology research ecosystem in which we all exist and work together to move the field forward. We invite you to join us to present and discuss your latest research, build relationships with your colleagues in academia, industry, and government, and advance the member-driven work of EBRC. Attendance at the Annual Meeting is open to all EBRC members, their lab members, employees of institutional members, and all SPA members. We also warmly welcome all those in the Research Triangle with an interest in engineering biology to join us. Thank you to our hosts at the Genetic Engineering and Society (GES) Center at North Carolina State University!

This year, we are excited to celebrate EBRC’s 10-year anniversary! Additional activities, sessions, and social mixers will also be held throughout the Research Triangle on June 1, 2026, the day before the meeting; look forward to more information about these industry- and SPA-dedicated events coming soon!

New session! Before the main meeting kicks off, please join us for “Advancing the Bioeconomy Industry Ecosystem” on June 1 from 3:30-7:30pm ET to continue to celebrate EBRC’s 10 Year Anniversary. The event will bring together representatives from government and venture capital alongside EBRC’s academic and research community. The session will explore how promising ideas in engineering biology move from the lab into the real world across the broader industry ecosystem, featuring a keynote style talk, moderated panel discussion, 3-minute flash talks, and close with a social mixer. Space is limited, so sign up here (separate link from normal registration)! (If you’re interested in giving a flash talk, please indicate so on the form.)

Registration:
The deadline to register has passed. To confirm your spot and offset some of the meal costs, there will be a nominal fee. If this fee is prohibitive for you or your lab members, please email helix@ebrc.org.

Abstract submissions for talks and posters are now open. Abstract submission is separate from registration. Submissions from all attendees are welcome! We encourage you to submit your latest, ongoing work as a mechanism to engage in community dialogue. Abstracts for talks are due March 30, 2026 and abstracts for posters are due on May 11, 2026.

IMPORTANT DATES:
March 30, 2026: Last day to submit talk abstracts
April 20, 2026: Notification of talk selection
April 29, 2026: Registration closes for those with EBRC-supported travel
May 1, 2026: Deadline for hotel and travel arrangements by EBRC
May 14, 2026: Registration closes
May 11, 2026: Last day to submit poster abstracts

Annual Meeting Venue:
Talley Student Union
North Carolina State University
Raleigh, NC

Meeting Hotel:
*Update* — Our block of rooms at the Residence Inn Raleigh Downtown (616 S. Salisbury Street, Raleigh, NC 27601) is now fully booked. We suggest you reach out to these nearby hotels if you need accommodations: Raleigh Marriott City Center, Sheraton Raleigh Hotel, Homewood Suites by Hilton Raleigh Downtown, and Tempo by Hilton Raleigh Downtown.

Transportation:
More information coming soon!

Travel Support:
We anticipate covering airfare and hotel expenses for:

  • Individuals selected as speakers from academia, including students and postdocs;
  • EBRC Academic Council members selected as Session Chairs; and
  • Student and Postdoc Association Board members who present a poster or are selected as speakers.

Individuals who will receive travel support will be contacted by email to complete their flight bookings. The meeting will conclude at 5:00PM on Wednesday, June 3 and we encourage those receiving travel support to find an evening flight if at all possible. Please contact helix@ebrc.org if you anticipate needing Sunday and/or Wednesday night accommodations. Please also note that travel support does not include the confirmation/meal fee. Email helix@ebrc.org if this fee is prohibitive. Please see EBRC’s full travel policy here.

We encourage you to make your travel plans early, as we will cap the level of airfare support provided by EBRC. Airfare must be booked by May 1 to be eligible for EBRC support.

Health and Safety:
We are committed to hosting a safe event. We will be closely watching CDC recommendations in addition to all relevant local and state guidelines leading up to the Meeting and make any changes necessary for health and safety.

Dress Code:
The EBRC Annual Meeting does not have a dress code. EBRC values diversity and individual expression — we encourage participants to come as they are and wish to present themselves to the world.

Bioinspiration: A Motivation for Investing in Foundational Biological Research in the U.S.

Publication Date: June 2026

Bioinspiration is a growing field that translates biological principles into engineering solutions, often yielding significant returns even from niche research. Bioinspired technologies have the potential to generate billions for the U.S. economy and contribute to millions of jobs in fields including construction, healthcare, and chemical manufacturing. To promote this growth, significant investment must be made in the innovation pipeline from foundational research to commercialization.

New EBRC Publication! Securing the U.S. Bioeconomy: A Managed Access Framework for Biotechnology Innovation

EBRC Science Policy Postdoctoral Fellow Jon Judd has published a new independent policy memo examining federal governance of biological data: Securing the U.S. Bioeconomy: A Managed Access Framework for Biotechnology Innovation.

The U.S. leads in biological data production, but fragmented governance and incompatible formats mean that data sitting in federal repositories today cannot fuel the AI-enabled discoveries the bioeconomy needs.

His memo argues for a managed-access approach and puts forward three recommendations:

  • Congress should authorize a DOE-led federated pilot program anchored at the National Labs to build and test the infrastructure for shared biological data access.
  • NIST should develop a standardized biological data ontology to establish the building blocks for AI-ready data across federal repositories.
  • OSTP should convene an interagency subcommittee to produce a unified data-use agreement, replacing the current patchwork of incompatible access requirements.

The memo reflects input from across the EBRC community and builds on the National Security Commission on Emerging Biotechnology’s call for improved federal biological data infrastructure. We encourage the broader community to read it and share reactions.

Read the full memo here.

Securing the U.S. Bioeconomy: A Managed Access Framework for Biotechnology Innovation

Publication Date: May 2026

Federal biological data is fragmented, siloed, and ungoverned at the moment AI makes integration most consequential. This memo proposes three complementary actions: a DOE-led federated pilot program to unify data access across federal repositories, a NIST-developed biological data ontology to enable machine-readable interoperability, and an OSTP/NSTC interagency subcommittee to replace incompatible agency-specific data-use agreements with a unified, tiered framework. Together, these recommendations build the governance infrastructure the U.S. bioeconomy needs to remain competitive and secure.

Mary Maxon

Advancing the Bioeconomy Industry Ecosystem – an EBRC networking event at SynBioBeta 2026

On the eve of SynBioBeta, come continue to celebrate the Engineering Biology Research Consortium (EBRC)’s 10 Year Anniversary of advancing engineering biology to address national and global needs with an evening of conversation, drinks, and light bites.

The event will feature Advancing the Bioeconomy’s Industry Ecosystem, bringing together leaders from the biotechnology industry to explore the challenges and opportunities in derisking the future of engineering biology innovation. It will also highlight how organizations, like EBRC, can serve as a convening platform, giving collective voice to the community’s needs and priorities.

Speakers include:

  • John Dileo, Senior Principal Biotechnologist (MITRE)
  • Rebecca Nugent, Venture Partner (Breakout Ventures)
  • James Diggans, Vice President, Policy and Biosecurity (Twist Bioscience)
  • Alina Meltaus, Chief of Staff (NSCEB)
  • India Hook-Barnard, CEO (EBRC)
  • More speakers TBA!

Panelists will share perspectives on what it takes to scale biotechnology solutions to address real-world challenges, and what they see as the most pressing priorities and exciting opportunities for the engineering biology community in the years to come.

Date and Time
May 4, 2026 from 5:00-8:00pm PT

Location
The Farmers Union
151 W. Santa Clara St
San Jose, CA 95113

Because space is limited, please register to help us plan. Hope to see you there!

Event Flyer

Andrew Arthur

Andrew Arthur brings nearly 30 years of strategic and commercial leadership in the mining industry to his role as CFO and Chief Commercial Development Officer at Endolith. He spent over 20 years at BHP, including a decade as a Vice President across copper strategy, resource engineering, and technical excellence. That tenure included leading strategy and business development for BHP’s copper portfolio from Santiago, Chile, and oversight of legacy asset optimization globally.

Before joining Endolith, Andrew ran his own advisory practice focused on copper legacy assets, working with operators to maximize recovery value and minimize closure risk — precisely the problem set Endolith’s biological intelligence platform is built to solve.

He brings deep expertise in mergers and acquisitions, joint ventures, strategic planning, and commercial development, and is a qualified accountant. At Endolith, he leads the financial and commercial functions as the company scales deployment with Tier 1 mining partners.

Liz Dennett

Liz Dennett is the founder and CEO of Endolith, a biological intelligence company improving critical mineral recovery in real mining environments. Endolith deploys adaptive microbial systems that integrate with existing heap leach infrastructure to increase copper recovery, with field-validated results from major mining operators including BHP.

Before founding Endolith, Liz was a Solutions Architect at Amazon Web Services, where she worked on scaling digital infrastructure and developed a clear view of the physical mineral constraints underlying the digital economy. That intersection — between the demand for critical materials and the limits of conventional extraction — became the foundation for Endolith’s approach.

Liz holds a PhD and brings together systems thinking, field deployment experience, and a deep conviction that biology, deployed intelligently, can close the gap between what mines produce and what they’re capable of.

Timmi Turley

Timmi Turley is currently a Principal Analyst at EBRC. Her 20+ years of professional experience spans higher education and research organizations. Her background includes leadership roles in higher education strategy, collaborative research initiatives, directing event and program management, and leading donor engagement programs. Most recently, she was a Special Projects Manager at BioMADE. She has a B.S. in Communication and a M.Ed in Higher and Postsecondary Education from Arizona State University.

Strengthening Safety and Security of Biological Research Globally in Support of the Biological Weapons Convention

This project seeks to support and promote global best practices in biorisk management and research oversight, thereby supporting States Parties’ national Biological Weapons Convention (BWC) implementation efforts. By working with policymakers, senior practitioners, laboratory operations and maintenance (O&M) personnel, and stakeholders across the research lifecycle, EBRC will endeavor to build community to support i) O&M for high containment labs, ii) review and oversight of high-risk research, and iii) the growth of empirically-based biosafety practices.

EBRC Sci Comm Workshop Series: “Communicating Science Effectively”

EBRC is excited to host “Communicating Science Effectively”, an interactive, virtual training series open to all EBRC members! Over the course of three 60-minute sessions, participants will learn research-based theories underlying effective science communication and have the opportunity to apply these principles through hands-on instruction, practice, and feedback. The series will culminate with an in-person session during the EBRC Annual Meeting (register here!). This is a great opportunity for anyone interested in leveling up their communication and engagement skills!

Because the sessions build on one another, participants are expected to attend all three virtual sessions.

Questions? Please feel free to reach out to Julietta (julietta@ebrc.org)!

Register Here


 

Workshop Series Schedule

Session 1: Sci Comm 101 (virtual) | Friday, March 20, 2026 (3 PM ET/12 PM PT)

During this initial session, participants will consider the aim of their communication and go through the basics of effective science communication.

Objectives include:

  • Learn how to define clear communication goals and align messaging with desired outcomes;
  • Explore strategies for identifying and understanding your audience’s background, expectations, and needs; and
  • Understand the basics of ensuring your key points are communicated clearly.

Participants will also engage in interactive discussions to share their communication and engagement goals, challenges, fears, and opportunities.

 

Session 2: Panel Discussion – Applying Sci Comm in Practice (virtual) | Thursday, April 16, 2026 (3 PM ET/12 PM PT)

During this session, a panel of Sci Comm experts across a variety of fields will share their experiences.

Discussion topics include:

  • Finding and knowing your audience—Panelists will share practical strategies for identifying target audiences, understanding their values and needs, and building meaningful connections.
  • The importance of the messenger—Panelists will discuss how credibility, trust, and identity influence how science is received.
  • Creating and delivering effective messages—Panelists will discuss examples of what makes a compelling story.
    Working with journalists, press officers and professional societies

Participants will additionally be invited to actively engage with the panel, ask questions, share perspectives, and seek expert advice relevant to their own science communication experiences.

 

Session 3: Crafting your message (virtual) | Friday, May 15, 2026 (3 PM ET/12 PM PT)

This final session will focus on best practices for communicating evidence and strategies for addressing issues such as uncertainty, biases and presenting numerical information

Objectives include:

  • Best practices for communicating evidence and numbers: what are the issues with using words without numbers, the need to communicate absolute risks, natural frequencies, etc;
  • Learn how to clearly communicate different types of uncertainty;
  • Align uncertainty information to the decision context; and
  • Understand how mental models and cognitive biases may affect people’s understanding of evidence and consider how to use transformative explanations and other communication tactics.

 

Final presentations (in-person) | June 3, 2026 (at the EBRC Annual Meeting)

Participants will prepare a Sci Comm product tailored to a specific audience, topic, and engagement platform (e.g., an Instagram live stream, interview for a local newspaper, a Bluesky thread) to be presented during a live, interactive session at the EBRC Annual Meeting open to all meeting attendees.

This session will offer a unique opportunity for participants to put the skills and strategies learned throughout the workshop series into practice and engage in meaningful dialogue with a broader scientific community.

 

Mia Negru

Mia Negru serves as Executive Director of Life With Artificials, a social engagement platform exploring how humans and intelligent systems coexist in areas such as health, work, governance, and everyday life. Through public dialogue, cross-sector partnerships, and policy-oriented initiatives, she works to connect researchers, innovators, regulators, and citizens—ensuring that emerging technologies evolve in alignment with democratic values, ethical principles, and social responsibility.

She studied International Business and Politics at Copenhagen Business School (CBS), where she built a solid understanding of regulatory systems, institutional decision-making, and public–private collaboration in complex policy environments.

Her passion for frontier innovation led her to engage with programs at Singularity University, deepening her focus on artificial intelligence, robotics, and synthetic biology and their long-term societal implications.

Lasse Helmer Pederson

Lasse Helmer Pedersen is a hands-on technologist and strategic advisor working at the intersection of advanced AI, engineering and health technology. As Strategic Advisor on technology for Zibra Holding ApS, he supports a portfolio of tech ventures with AI strategy, innovation governance, and the design of resilient technology ecosystems. Previously, Lasse served as CTO at MindFuture, where he helped build an innovation hub around real-world, responsible applications of artificial intelligence. A long-time practitioner, he has led technology, product development, and IT organizations across telecoms, infrastructure, and software, giving him a practical understanding of how to move complex technologies from concept to deployment at scale.

Lasse is part of the core team in Life with Artificials, contributing strategic advice on how humans and AI can coexist in ways that are safe, beneficial, and aligned with societal values. He is particularly interested in how cutting-edge AI can accelerate engineering biology and health tech while maintaining robustness, security, and public trust.

Chloe Franklin

Chloe Franklin is Director of National Programs at the BioBuilder Educational Foundation, a nonprofit dedicated to providing students exposure to real-world STEM applications and industry-relevant skills to prepare the largest and most diverse group of learners for colleges and careers in life science. She leads educator training initiatives and the BioBuilderClub, which invites high school students to tackle local and global challenges through synthetic biology with the support of scientific mentors. Chloe holds a bachelor’s degree in biology from the University of Chicago and a master’s degree in educational studies with a focus on inquiry-based science instruction.